Cargando…
Limiting Acute Kidney Injury Progression In Sepsis: Study Protocol and Trial Simulation*
OBJECTIVES: To describe study design considerations and to simulate a trial of biomarker-guided sepsis management aimed to reduce acute kidney injury (acute kidney injury). Tissue inhibitor of metalloproteinases-2 and insulin-like growth factor-binding protein 7, urinary biomarkers of cell-cycle arr...
Autores principales: | Molinari, Luca, Heskia, Fabienne, Peerapornratana, Sadudee, Ronco, Claudio, Guzzi, Louis, Toback, Seth, Birch, Robert, Beyhaghi, Hadi, Kwan, Thomas, Kampf, J. Patrick, Yealy, Donald M., Kellum, John A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439672/ https://www.ncbi.nlm.nih.gov/pubmed/33927121 http://dx.doi.org/10.1097/CCM.0000000000005061 |
Ejemplares similares
-
Sepsis-Associated Acute Kidney Disease
por: Peerapornratana, Sadudee, et al.
Publicado: (2020) -
Feasibility Assessment of a Biomarker-Guided Kidney-Sparing Sepsis Bundle: The Limiting Acute Kidney Injury Progression In Sepsis Trial
por: Gómez, Hernando, et al.
Publicado: (2023) -
Utility of Biomarkers for Sepsis-Associated Acute Kidney Injury Staging
por: Molinari, Luca, et al.
Publicado: (2022) -
The effect of polymyxin B hemoperfusion on modulation of human leukocyte antigen DR in severe sepsis patients
por: Srisawat, Nattachai, et al.
Publicado: (2018) -
Use of Biomarkers to Identify Acute Kidney Injury to Help Detect Sepsis in Patients With Infection
por: Kellum, John A., et al.
Publicado: (2021)